Bruker Corporation $BRKR Position Increased by Vanguard Personalized Indexing Management LLC

Key Points

• Vanguard Personalized Indexing Management LLC increased its position in Bruker Corporation by 96.2% in Q2, owning 20,230 shares worth $834,000.
• Bruker has a current P/E ratio of 71.12 and a market cap of $5.61 billion, with shares trading down 3.2% at $36.98.
• The company recently reported an earnings miss, with a net profit margin of just 2.31% and revenues of $797.4 million, which fell short of analysts' expectations.

Vanguard Personalized Indexing Management LLC raised its position in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) by 96.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 20,230 shares of the medical research company's stock after buying an additional 9,918 shares during the quarter. Vanguard Personalized Indexing Management LLC's holdings in Bruker were worth $834,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Teacher Retirement System of Texas boosted its holdings in shares of Bruker by 5.1% during the first quarter. Teacher Retirement System of Texas now owns 29,045 shares of the medical research company's stock worth $1,212,000 after purchasing an additional 1,422 shares during the period. Fifth Third Bancorp boosted its holdings in shares of Bruker by 54.2% during the first quarter. Fifth Third Bancorp now owns 1,109 shares of the medical research company's stock worth $46,000 after purchasing an additional 390 shares during the period. Amundi boosted its holdings in shares of Bruker by 373.3% during the first quarter. Amundi now owns 42,503 shares of the medical research company's stock worth $1,774,000 after purchasing an additional 33,522 shares during the period. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Bruker by 35.6% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 40,450 shares of the medical research company's stock worth $1,717,000 after purchasing an additional 10,624 shares during the period. Finally, Vaughan Nelson Investment Management L.P. boosted its holdings in shares of Bruker by 71.2% during the second quarter. Vaughan Nelson Investment Management L.P. now owns 1,293,645 shares of the medical research company's stock worth $53,298,000 after purchasing an additional 537,845 shares during the period. 79.52% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

BRKR has been the topic of a number of research reports. Weiss Ratings restated a "sell (d+)" rating on shares of Bruker in a report on Wednesday, October 8th. Barclays dropped their price objective on Bruker from $43.00 to $40.00 and set an "overweight" rating on the stock in a report on Thursday, October 2nd. Stifel Nicolaus set a $40.00 price objective on Bruker and gave the stock a "hold" rating in a report on Tuesday, August 5th. Jefferies Financial Group set a $60.00 price objective on Bruker and gave the stock a "buy" rating in a report on Monday, August 4th. Finally, Bank of America dropped their price objective on Bruker from $61.00 to $50.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. Five equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $51.00.

Insider Activity

In related news, Director Cynthia M. Friend sold 3,535 shares of Bruker stock in a transaction dated Friday, September 12th. The stock was sold at an average price of $32.25, for a total value of $114,003.75. Following the completion of the transaction, the director directly owned 18,016 shares of the company's stock, valued at $581,016. The trade was a 16.40% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 27.30% of the company's stock.

Bruker Trading Down 3.2%

Shares of Bruker stock opened at $36.98 on Monday. The company's fifty day simple moving average is $33.48 and its 200-day simple moving average is $36.98. The company has a market cap of $5.61 billion, a price-to-earnings ratio of 71.12, a PEG ratio of 5.18 and a beta of 1.20. The company has a current ratio of 1.61, a quick ratio of 0.70 and a debt-to-equity ratio of 1.31. Bruker Corporation has a 1 year low of $28.53 and a 1 year high of $64.64.

Bruker (NASDAQ:BRKR - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The medical research company reported $0.32 earnings per share for the quarter, missing analysts' consensus estimates of $0.33 by ($0.01). Bruker had a return on equity of 17.89% and a net margin of 2.31%.The business had revenue of $797.40 million for the quarter, compared to analyst estimates of $811.17 million. During the same quarter in the prior year, the firm earned $0.52 EPS. The firm's quarterly revenue was down .4% on a year-over-year basis. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. As a group, sell-side analysts expect that Bruker Corporation will post 2.69 EPS for the current year.

Bruker Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 3rd. Shareholders of record on Tuesday, September 23rd were issued a dividend of $0.05 per share. The ex-dividend date of this dividend was Tuesday, September 23rd. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.5%. Bruker's dividend payout ratio (DPR) is presently 38.46%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.